- Published on:
Havana, Sep 22 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) reported that the Abdala Covid-19 vaccine is 90 percent effective in seriously ill patients affected by the SARS-CoV-2 virus, as reported by the local press.







